Skip to content

Telerehabilitation in Individuals With Rheumatic Disease

Biopsychosocial Exercise Model Via Telerehabilitation in Individuals With Rheumatic Disease During the COVID-19 Pandemic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05568485
Enrollment
28
Registered
2022-10-05
Start date
2020-12-10
Completion date
2021-12-20
Last updated
2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic Diseases

Keywords

Biopsychosocial, rheumatology, remote care, holistic

Brief summary

increasing the prevalence of exercise models designed in accordance with the biopsychosocial model is very important in terms of ensuring the sustainability of these models with telerehabilitation in periods such as epidemics and pandemics. The aim of this study was to investigate the effects of a biopsychosocial exercise model provided via telerehabilitation in individuals with rheumatic diseases during the COVID-19 pandemic.

Detailed description

Telerehabilitation was applied to the group with rheumatism in 3 sessions a week for 24 weeks via a social texting program. The intervention sessions consisted of 10 minutes of dance therapy-authentic movement, 40 minutes of exercises, and 10 more minutes of dance therapy. This exercise content was based on a biopsychosocial model, named the Cognitive Exercise Therapy Approach (BETY) which was used in the study, and it was a method that patients already practiced before the pandemic. At the beginning, at the 12th week and 24th week, the Health Assessment Questionnaire (HAQ), the Hospital Anxiety and Depression Scale (HADS), the BETY Biopsychosocial Questionnaire (BETY-BQ) were applied.

Interventions

OTHERTelerehabilitation was applied to the group with rheumatism

Telerehabilitation was applied to the group with rheumatism in 3 sessions a week for 24 weeks via a social texting program. The intervention sessions consisted of 10 minutes of dance therapy-authentic movement, 40 minutes of exercises, and 10 more minutes of dance therap

Sponsors

Eastern Mediterranean University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

members of an exercise group before the pandemic at the physiotherapy and rehabilitation department of a university.

Exclusion criteria

* Individuals who had difficulty in cooperation

Design outcomes

Primary

MeasureTime frameDescription
BETY Biopsychosocial Questionnaire (BETY-BQchange will be assessed at 12th week and 24th weekan assessment tool that evaluates biopsychosocial involvement and assesses pain, function, sexual behavior, and social and psychological aspects. The scoring of the questionnaire is made using a 5-point Likert system. Each item is scored as 0 = No, never, 1 = Yes, rarely, 2 = Yes, sometimes, 3 = Yes, often, or 4 = Yes, always. A high score indicates a low biopsychosocial status

Secondary

MeasureTime frameDescription
Health assessment questionnairechange will be assessed at 12th week and 24th weekIt includes 20 questions and 8 components including dressing, sitting, eating, walking, hygiene, reaching out, comprehending, and activities of daily living. Each answer is rated between 0 and 3 points, 0 = No difficulty, 1 = Somewhat difficult, 2 = Very difficult, and 3 = I can never do it, and a high score indicates low functionality \[18\]. HAQ scores of \>1 are considered to indicate the presence of disability
hospital qnxiety and depression scalechange will be assessed at 12th week and 24th week. It is a 14-item scale that consists of Anxiety (HADS-A) and Depression (HADS-D) subscales. The answer to each item is scored between 0 and 3 using the 4-point Likert scoring format, and each subscale has a score range between 0 and 21. Scores between 0 and 7 for each subscale are considered normal, those between 8 and 10 are considered mild anxiety/depression, and those from 11 to 21 are considered moderate-severe anxiety/depression

Countries

Cyprus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026